April 27, 2015
Citing years of shoddy manufacturing, the U.S. Food and Drug Administration on Monday slapped Medtronic Inc. and two executives with a far-reaching consent decree that will block most sales of a popular drug-infusion pump and force the device maker to undertake extensive reforms.